According to information provided in the Congressional Budget Office’s 2006 study, Research and Development in the Pharmaceutical Industry, it costs pharmaceutical companies an average of 12 years and $800 million dollars to create and bring to market a drug that is based on a┬ánew molecular entity (NME). In sharp contrast, drugs that are based on